Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

83.85

+0.12 (0.14%)

At close: Jul 27, 2026, 4:00 PM EDT

83.63

-0.22 (-0.26%)

After-hours: Jul 27, 2026, 7:34 PM EDT

Crinetics Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	114.34	101.54	264.55	54.9	32.67	200.7
Short-Term Investments	1,177	926.35	1,090	503.66	301.75	133.01
Cash & Short-Term Investments	1,291	1,028	1,354	558.56	334.43	333.71
Cash Growth	1.35%	-24.09%	142.42%	67.02%	0.21%	95.29%
Accounts Receivable	5.68	0.59	-	-	-	-
Inventory	3.06	2.02	-	-	-	-
Other Current Assets	22.36	17.84	21.32	15.6	10.76	11.01
Total Current Assets	1,322	1,048	1,375	574.15	345.18	344.72
Net Property, Plant & Equipment	53.29	54.79	55.58	57.43	4.99	4.72
Long-Term Investments	-	-	-	0.47	-	1.01
Other Long-Term Assets	25.62	23.13	3.63	3.3	2.01	0.57
Total Assets	1,401	1,126	1,435	635.35	352.18	351.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	37.49	41.77	21.47	23.2	15.35	8.47
Accrued Expenses	25.79	35.58	28.89	14.52	9.08	6.59
Current Portion of Leases	6.54	6.49	7.15	4.17	1.05	-
Unearned Revenue	1.27	1.24	2.18	2.06	2.24	-
Other Current Liabilities	-	-	-	-	-	0.94
Total Current Liabilities	71.09	85.07	59.68	43.94	27.72	16
Long-Term Leases	41.32	42.05	44.57	47.56	2.02	3.07
Other Long-Term Liabilities	8.27	7.05	5.53	4.75	6.1	0
Total Long-Term Liabilities	49.59	49.1	50.1	52.31	8.13	3.08
Total Liabilities	120.68	134.17	109.79	96.25	35.85	19.07

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	2,828	2,408	2,276	1,192	759.43	607.58
Treasury Stock	-1.03	-0.11	-	-	-	-
Accumulated Other Comprehensive Income	-1.25	1.87	0.96	0.98	-3.93	-0.38
Retained Earnings	-1,545	-1,417	-952.11	-653.7	-439.17	-275.26
Shareholders' Equity	1,281	992.08	1,325	539.11	316.33	331.94
Total Liabilities & Equity	1,401	1,126	1,435	635.35	352.18	351.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	47.86	48.54	51.72	51.73	3.08	3.07
Net Cash (Debt)	1,243	979.35	1,302	506.83	331.35	330.63
Net Cash Growth	1.65%	-24.80%	156.96%	52.96%	0.22%	98.14%
Net Cash Per Share	12.85	10.41	16.12	8.73	6.37	8.60
Book Value	1,281	992.08	1,325	539.11	316.33	331.94
Book Value Per Share	13.23	10.55	16.40	9.28	6.09	8.64
Tangible Book Value	1,281	992.08	1,325	539.11	316.33	331.94
Tangible Book Value Per Share	13.23	10.55	16.40	9.28	6.09	8.64

SEC Filings: 10-K · 10-Q